Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights


Mitigating risk in the gene therapy supply chain

Chad Presher

Supply Chain Focus: Biologistics Strategy for Scale-Up

Chad Presher is an Associate Director of Clinical Drug supply at Biogen. In this role Chad supports the clinical supply chains for Biogen’s Rare Disease Therapeutic Area. Prior to joining Biogen, Chad held commercial supply chain roles at Pfizer and Wyeth. Chad holds an MBA and a BS in Biology from the University of New Hampshire.

DOI: 10.18609/cgti.2019.114
Citation: Cell & Gene Therapy Insights 2019; 5(9), 1069–1073.
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog